No results found.

Screeners (33,980)

Signal Glossary

DTL Breach Warning
Price has pushed through the Demand Threshold Line (those orange bars). It flags price vulnerability at/through that boundary for the current week.
Smart Money Buy
A โ€œsmart moneyโ€ star printed on the chart. It marks concentrated, high-quality buying activity often seen ahead of stronger moves. (We only log it when the star appears.)
Investor Buy
An โ€œinvestor buyโ€ star printed on the chart. It reflects broader, more general momentum by investors. (Again, only logged when the star appears.)
Accumulation
A green bar (often within a negative market cycle). Each green bar signals steady, systematic buying/absorbing of supply.
Distribution
The counterpart to accumulation. It marks persistent selling/handing off of shares - supply is dominating and pressure is to the downside.
Ribbon Change
The ribbon flips color (red โ†” green). We log the first bar of a new segment, which signals a regime shift in the underlying indicator.
Threshold Breach (Buy)
The composite indicator crosses down through the dynamic Bottom threshold. Itโ€™s a โ€œbuy-sideโ€ extreme that often precedes an upward move.
Threshold Breach (Sell)
The composite indicator crosses up through the dynamic Top threshold. Itโ€™s a โ€œsell-sideโ€ extreme that often precedes a downward move.
Baseline Crossover
The tracked metric crosses its baseline (typically zero). Crossing up suggests improving conditions; crossing down suggests deterioration.
Demand โˆ’1 Crossover
Price crosses up through the โ€œโˆ’1 demandโ€ reference level. It signals a possible early improvement in demand conditions after a weak phase.
Valuation Change
A change in our valuation classification (e.g., from overvalued to fairly valued). It captures a material update to the valuation state for screening.
Info Update
A notable informational event (e.g., earnings/guidance/corporate update) that we tag for the screener so you can filter around fresh developments.
ML Turned Positive
The Magic Line (smoothed activity) crosses above zero and turns positive. It indicates a shift toward constructive momentum/pressure.
ML Turned Negative
The Magic Line crosses below zero and turns negative. It indicates a shift toward weakening momentum/pressure.

Nasdaq

(NASDAQ)
ACIU
AC Immune SA
?
Accumulation ?
No valuation data
?
โ€”
โ€”
AMAT
Applied Materials, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
AMST
Amesite Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ARCT
Arcturus Therapeutics Holdings Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ARTW
Art's-Way Manufacturing Co., Inc.
?
Accumulation ?
C1 F2 R2
?
Moderately Undervalued
Target: 2.60 ?
BSY
Bentley Systems, Incorporated
?
Accumulation ?
C2 F3 O1 R1
?
Deeply Overvalued
Negative ?
BTCS
BTCS Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CCEP
Coca-Cola Europacific Partners PLC
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CHCI
Comstock Holding Companies, Inc.
?
Accumulation ?
C3 F3 O3 R3
?
Fairly Valued
Target: 15.65 ?
CINF
Cincinnati Financial Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CLBT
Cellebrite DI Ltd.
?
Accumulation ?
C1 F1 O3 R2
?
Significantly Overvalued
Target: 8.00 ?
CRNX
Crinetics Pharmaceuticals, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CRVS
Corvus Pharmaceuticals, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CSX
CSX Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DDOG
Datadog, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DRS
Leonardo DRS, Inc.
?
Accumulation ?
C2 F2 O3 R3
?
Significantly Overvalued
Target: 21.00 ?
ETON
Eton Pharmaceuticals, Inc.
?
Accumulation ?
C2 F1 O2 R1
?
Significantly Overvalued
Target: 10.60 ?
EVER
EverQuote, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Significantly Overvalued
Target: 12.89 ?
EXAS
Exact Sciences Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
GBDC
Golub Capital BDC, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Significantly Undervalued
Target: 16.81 ?
HCM
HUTCHMED (China) Limited
?
Accumulation ?
C3 F1 O1 R3
?
Extremely Undervalued
Positive ?
HIMX
Himax Technologies, Inc.
?
Accumulation ?
C1 O1 R1
?
Moderately Overvalued
Target: 7.20 ?
IDXX
IDEXX Laboratories, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
IESC
IES Holdings, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Significantly Overvalued
Target: 261.80 ?
JVA
Coffee Holding Co., Inc.
?
Accumulation ?
C2 F2 R1
?
Significantly Undervalued
Target: 4.74 ?
LAMR
Lamar Advertising Company
?
Accumulation ?
C3 F1 O1 R1
?
Significantly Overvalued
Target: 69.97 ?
LASR
nLIGHT, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
LE
Lands' End, Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Significantly Overvalued
Target: 11.20 ?
METC
Ramaco Resources, Inc.
?
Accumulation ?
C1 O1 R2
?
Deeply Undervalued
Positive ?
MFH
Mercurity Fintech Holding Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
MGNI
Magnite, Inc.
?
Accumulation ?
C2 F2 O2 R1
?
Significantly Undervalued
Target: 18.40 ?
MTRX
Matrix Service Company
?
Accumulation ?
No valuation data
?
โ€”
โ€”
NAGE
Niagen Bioscience, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Significantly Overvalued
Target: 4.80 ?
NCNO
nCino, Inc.
?
Accumulation ?
C2 F1 O2 R3
?
Significantly Overvalued
Target: 17.40 ?
OKTA
Okta, Inc.
?
Accumulation ?
C3 F2 O2 R3
?
Deeply Overvalued
Negative ?
OPRA
Opera Limited
?
Accumulation ?
C2 F2 O3 R1
?
Significantly Undervalued
Target: 17.93 ?
OXLC
Oxford Lane Capital Corp.
?
Accumulation ?
C3 F3 O3 R2
?
Moderately Overvalued
Target: 13.80 ?
PATK
Patrick Industries, Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Deeply Undervalued
Target: 157.80 ?
PEGA
Pegasystems Inc.
?
Accumulation ?
C3 F2 O2 R2
?
Significantly Overvalued
Target: 37.30 ?
PLUS
ePlus inc.
?
Accumulation ?
C3 F1 O3 R2
?
Significantly Undervalued
Target: 102.10 ?
RGLD
Royal Gold, Inc.
?
Accumulation ?
C3 F2 O1 R3
?
Deeply Overvalued
Negative ?
ROOT
Root, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SCSC
ScanSource, Inc.
?
Accumulation ?
C1 F1 O2 R2
?
Significantly Undervalued
Target: 47.45 ?
SGRY
Surgery Partners, Inc.
?
Accumulation ?
C2 F1 O3 R1
?
Significantly Overvalued
Target: 16.04 ?
SLNO
Soleno Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SNY
Sanofi
?
Accumulation ?
No valuation data
?
โ€”
โ€”
TFSL
TFS Financial Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
TSAT
Telesat Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
VEON
VEON Ltd.
?
Accumulation ?
C3 F3 O1 R1
?
Moderately Undervalued
Target: 47.20 ?
ZG
Zillow Group, Inc.
?
Accumulation ?
C1 F1 O3 R1
?
Significantly Overvalued
Target: 43.71 ?